Back
AbCellera Biologics Vs. ESSA Pharma Industry Stock Comparison
Buy
60
ABCL
AbCellera Biologics
Last Price:
2.81
Seasonality Move:
-23.52%
Sell
32
EPIX
ESSA Pharma
Last Price:
1.65
Seasonality Move:
40.1%
Buy
60
AbCellera Biologics (ABCL)
is a Buy
Is AbCellera Biologics a Buy, Sell or Hold?
- The current AbCellera Biologics [ABCL] share price is $2.81. The Score for ABCL is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- ABCL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
ESSA Pharma (EPIX)
is a Sell
Is ESSA Pharma a Buy, Sell or Hold?
- The current ESSA Pharma [EPIX] share price is $1.64. The Score for EPIX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- EPIX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABCL Stock Price Chart
What is AbCellera Biologics's stock price today?
-
The AbCellera Biologics share price today is $2.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABCL is experiencing selling pressure, which indicates risk of future bearish movement.
EPIX Stock Price Chart
What is ESSA Pharma's stock price today?
-
The ESSA Pharma share price today is $1.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EPIX is experiencing slight selling pressure.
ABCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 47.51 | Sell |
| Chaikin Money Flow: | -2108907 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.74 - 3) | Sell |
| Bollinger Bands (100): | (2.53 - 2.93) | Buy |
EPIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 24.35 | Sell |
| Chaikin Money Flow: | -88775 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.68 - 1.8) | Sell |
| Bollinger Bands (100): | (2.6 - 6.36) | Sell |
ABCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.92 | Sell |
| 20-day SMA: | 2.86 | Sell |
| 50-day SMA: | 2.78 | Buy |
| 200-day SMA: | 3.3 | Sell |
| 8-day EMA: | 2.91 | Sell |
| 20-day EMA: | 2.89 | Sell |
| 50-day EMA: | 2.82 | Sell |
| 200-day EMA: | 3.38 | Sell |
EPIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.68 | Sell |
| 20-day SMA: | 1.73 | Sell |
| 50-day SMA: | 3.35 | Sell |
| 200-day SMA: | 5.59 | Sell |
| 8-day EMA: | 1.68 | Sell |
| 20-day EMA: | 1.91 | Sell |
| 50-day EMA: | 2.95 | Sell |
| 200-day EMA: | 4.81 | Sell |
AbCellera Biologics Earnings Growth & ABCL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.13 per share, and a decrease next year of $0.08 per share.
ESSA Pharma Earnings Growth & EPIX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.22 per share.
AbCellera Biologics Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ESSA Pharma Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||